insulin pricing: eli lilly ceo | mad money | cnbc
Published 4 years ago • 3.1K plays • Length 8:58Download video MP4
Download video MP3
Similar videos
-
6:08
eli lilly ceo on slashing insulin prices, approval timelines for weight-loss and alzheimer's drugs
-
6:05
eli lilly ceo david ricks on q2 results: seeing unbelievable demand for zepbound and mounjaro
-
2:14
eli lilly cuts insulin prices by 70%
-
9:11
eli lilly ceo: competition in pharma | mad money | cnbc
-
1:44
eli lilly says price for humalog insulin is down 8.1%
-
9:28
elizabeth warren says eli lilly failed to provide cheaper insulin. ceo says ‘nonsense’
-
3:26
tema etfs: supply is the real issue when it comes to weight loss drugs
-
8:19
why insulin is so expensive | so expensive
-
4:09
lilly pulls ahead of novo in obesity drug race
-
2:39
eli lilly ceo says warren's claims the company failed on cheaper insulin is 'nonsense'
-
5:46
eli lilly ceo disputes elizabeth warren's claim that the company failed to provide cheaper insulin
-
2:37
eli lilly ceo: 'it's time for a change' in the drug pricing system
-
2:43
eli lilly cuts insulin prices by 70%
-
7:33
watch cnbc's full interview with eli lilly ceo david ricks
-
1:54
eli lilly blows past estimates, hikes guidance as zepbound, mounjaro sales soar
-
9:43
eli lilly ceo on quarterly earnings beat, pharma policy, and more
-
5:53
eli lilly ceo on earnings and drug pricing
-
9:22
eli lilly ceo discusses its coronavirus antibody drug and the latest on its breast cancer treatment
-
4:26
eli lilly ceo david ricks breaks down second-quarter earnings and drug pipeline
-
0:54
how eli lilly’s insulin price cut affects big pharma
-
2:55
eli lilly's experimental obesity drug could be 'revolutionary,' says jim cramer
-
3:07
jim cramer: eli lilly stock represents real value